Literature DB >> 15986225

Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology.

Jodie Newman1, Robert A Rissman, Floyd Sarsoza, Ronald C Kim, Malcolm Dick, David A Bennett, Carl W Cotman, Troy T Rohn, Elizabeth Head.   

Abstract

Alzheimer's disease (AD), Pick's disease (PiD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and dementia with Lewy bodies (DLB) are diseases associated with the accumulation of tau or alpha-synuclein. In AD, beta-amyloid (Abeta)-associated caspase activation and cleavage of tau at Asp421 (DeltaTau) may be an early step in neurofibrillary tangle (NFT) formation. To examine whether DeltaTau accumulates in other diseases not characterized by extracellular Abeta accumulation, we examined PiD, PSP, and CBD cases in comparison to those without extensive tau accumulation including frontotemporal lobar degeneration without Pick bodies (FTLD) and control cases. Additionally, we studied DeltaTau accumulation in DLB cases associated with intracellular alpha-synuclein. DeltaTau was observed in all disease cases except non-PiD FTLD and controls. These results demonstrate that the accumulation of DeltaTau may represent a common pathway associated with abnormal accumulation of intracellular tau or alpha-synuclein and may be relatively less dependent on the extracellular accumulation of Abeta in non-AD dementias.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15986225     DOI: 10.1007/s00401-005-1027-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  Frontal cortex neuropathology in dementia pugilistica.

Authors:  Tommy Saing; Malcolm Dick; Peter T Nelson; Ronald C Kim; David H Cribbs; Elizabeth Head
Journal:  J Neurotrauma       Date:  2012-04-10       Impact factor: 5.269

2.  Apoptosis in transgenic mice expressing the P301L mutated form of human tau.

Authors:  Rita M Ramalho; Ricardo J S Viana; Rui E Castro; Clifford J Steer; Walter C Low; Cecília M P Rodrigues
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

3.  Overview and findings from the religious orders study.

Authors:  David A Bennett; Julie A Schneider; Zoe Arvanitakis; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

Review 4.  Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.

Authors:  Mansi R Khanna; Jane Kovalevich; Virginia M-Y Lee; John Q Trojanowski; Kurt R Brunden
Journal:  Alzheimers Dement       Date:  2016-10       Impact factor: 21.566

5.  Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease.

Authors:  Natalia Louneva; Julia W Cohen; Li-Ying Han; Konrad Talbot; Robert S Wilson; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

Review 6.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

7.  Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.

Authors:  Brian M Dufty; Lisa R Warner; Sheng T Hou; Susan X Jiang; Teresa Gomez-Isla; Kristen M Leenhouts; Julia T Oxford; Mel B Feany; Eliezer Masliah; Troy T Rohn
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 8.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

9.  Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy.

Authors:  Patrice Delobel; Isabelle Lavenir; Graham Fraser; Esther Ingram; Max Holzer; Bernardino Ghetti; Maria Grazia Spillantini; R Anthony Crowther; Michel Goedert
Journal:  Am J Pathol       Date:  2007-12-13       Impact factor: 4.307

10.  Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3.

Authors:  Joonil Jung; Kexiang Xu; Derek Lessing; Nancy M Bonini
Journal:  Hum Mol Genet       Date:  2009-09-25       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.